The temporal positivity rate of SARS-CoV-2 in different clinical samples
Résumé
Abstract The aim of this study is to evaluate the diagnostic value of different clinical samples from humans such as blood/serum, stool, and urine as compared to the routinely used nasopharyngeal swab samples for the detection of SARS-CoV2 in COVID-19 patients. We followed COVID-19 patients for three weeks and collected samples on three occasions that is, on the day of admission to the hospital (Day zero), after one week (Day-8), and after the second week (Day-15). The data shows that on the day of the admission of the patients, NPS has a 64% positivity rate, followed by stool, urine, and serum, 38%, 18%, and 17%, respectively. And we observed a nearly similar pattern of positivity rate in the subsequent week’s samples.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 09/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →